The $203B Supplement Industry Needs a Stripe for Evidence
The NIH has the data. NatMed Pro serves clinicians. Nobody's built the developer-friendly API for consumer wellness apps drowning in supplement chaos.
Health & Bio explores the business of well-being — from biotech breakthroughs to everyday wellness tools. Each idea here lives at the intersection of science, data, and human care.
The NIH has the data. NatMed Pro serves clinicians. Nobody's built the developer-friendly API for consumer wellness apps drowning in supplement chaos.
Big Beverage is buying culture, not chemistry. Mushroom coffee incumbents still sell generic benefits—leaving identity-first positioning wide open for micro-tribe operators.
Acoustic sensors detect livestock respiratory disease 72 hours before symptoms, at 40x lower cost than smart collars—riding precision farming's shift from hardware to intelligence.
TikTok couples are running relationship tests with 56M+ views. No product captures the data. Gottman's research proves the science.
Hybrid workers skip breakfast 39% of the time, eating at desks when they do—creating a TikTok-native convenience play beyond traditional CPG channels.
Chicago's public health vending pilot revealed a massive tracking gap across thousands of machines dispensing Narcan, period products, and books nationwide.
Physical therapists with 5M YouTube subscribers launched $2,499 massage chairs on Amazon, proving creators can sell high-ticket hardware with zero customer acquisition cost.
FlavCity's scanner app tracked 18M users' dietary constraints before launching CPG products, reversing the traditional brand-building sequence with data-first manufacturing.